BCL-2 inhibitors, such as venetoclax (Venclexta) work by targeting the BCL-2 protein, which plays a key role in preventing apoptosis, or programmed cell death. According to John Seymour, MD, ...

Januar 2025A team of Jülich scientists used a special RNA molecule to specifically attack and destroy glioblastoma cancer cells. The selectively ...

Like workers at a factory or office, proteins in a cell must be in the right department to do their jobs. But scientists have ...

Animals have been used in scientific research for centuries. Starting in the 20th century, the use of animal models for different pathologies became standa | Health And Medicine ...

Anti-inflammatory macrophages play crucial roles in various diseases, including cancer, autoimmune disorders, and wound ...

Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off a dangerous chain of ...

China NMPA approves Astellas Pharma’s Padcev in combination with Keytruda to treat advanced bladder cancer: Tokyo Thursday, January 9, 2025, 09:00 Hrs [IST] Astellas Pharma Inc.

In a study published today in the Journal of Clinical Investigation, Fred Hutch Cancer Center cancer chemical biologist ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

A study has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal type of brain cancer.

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.